This month we wish the best of luck to our CEO Josefin Damm who's going on parental leave. Dr. Andreas Nilsson is taking over her role as CEO of the company.
We welcome our new COO & Regulatory Manager Dr. Andreas Nilsson. Andreas has an impressive research background in Orthopaedics with specialization in abnormal leg tissue pressures. He is also a keen horseback rider and user of Lundatex® Horse.
Interview published in Alingsås Tidning (Alingsås Newspaper) with our CEO Josefin Damm, about our newly launched compression product Lundatex® system.
PressCise inventor, Professor Torbjörn Lundh, from Chalmers Technical University, Gothenburg, was invited to present his inventions at "Venous updates from the world" at the Institute of Translational Medicine and Surgery in Ferrara, Italy.
PressCise receives its first order of Lundatex® system.
Today we started up our clinical study with the compression device Lundatex® system at the Leg Ulcer Clinic at Skaraborgs Hospital in Skövde, Sweden.
The first patient is now enrolled in a pilot patient case study conducted by Dr. Samek in Slovakia, evaluating our medical compression device Lundatex® system. In the coming months we look forward to conduct clinical trials and patient cases together with a Swedish hospital and Prof. Christina Lindholm, Prof. Mosti with italian patients and with Dr. Rolf Jelnes and the Danish home care.
We are proud to announce that our planned clinical patient study at Skaraborgs Hospital's Leg Ulcer Clinic in Skövde, Sweden has received support from both Smart Textiles and Medtech4Health. The study will be conducted in collaboration with Swedish Professor Christina Lindholm and Italian Professor Giovanni Mosti,
March 6 - 8
PressCise will be attending the medical conference EVC, and the ICC-meeting in Maastricht, Netherlands.
We also had the pleasure to meet the world famous classical artist and violin player André Rieu at the conference. Here together with the Slovakian surgeon Dr. Peter Samek.
© 2021 by PressCise AB